The IRDiRC Chrysalis Task Force: making rare disease research attractive to companies.
Beaverson KL, Julkowska D, Letinturier MCV, Aartsma-Rus A, Austin J, Bueren J, Frost S, Hamamura M, Larkindale J, LaRosa G, Magenheim R, Merico A, Pasmooij AMG, Pirard V, Ekow Thomford N, Wada M, Wong-Rieger D, Hartman AL.
Beaverson KL, et al. Among authors: magenheim r.
Ther Adv Rare Dis. 2023 Jul 29;4:26330040231188979. doi: 10.1177/26330040231188979. eCollection 2023 Jan-Dec.
Ther Adv Rare Dis. 2023.
PMID: 37529076
Free PMC article.